Interim analysis of the largest prospective trial to date in adult CD20-positive post-transplant lymphoproliferative disorder (PTLD): Introducing risk-stratified sequential treatment (RSST).
暂无分享，去创建一个
J. Zaucha | P. Reinke | H. Lehmkuhl | H. Riess | G. Verhoef | V. Leblond | M. Dreyling | T. Tousseyn | S. Choquet | M. Subklewe | F. Morschhauser | R. Trappe | D. Dierickx | I. Anagnostopoulos | R. Neuhaus | P. Mollee | C. Tarella | H. Zimmermann | U. Duehrsen | A. Huettmann